VanEck Vectors Biotech ETF Stock Forecast, Price & News

-1.55 (-0.88 %)
(As of 04/12/2021 03:06 PM ET)
Today's Range
Now: $175.37
50-Day Range
MA: $176.89
52-Week Range
Now: $175.37
Volume190 shs
Average Volume13,013 shs
Market Capitalization$494.89 million
P/E RatioN/A
Dividend Yield0.34%
The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.

Basic Details

Issuer Van Eck
Fund NameVanEck Vectors Biotech ETF
Tax ClassificationRegulated Investment Company
Inception Date12/20/2011
Fund ManagerHao-Hung Peter Liao, Guo Hua Jason Jin

Fund Focus

Asset ClassEquity
BenchmarkMarket Vectors US Listed Biotech 25 Index
FocusHealth Care
Development LevelDeveloped Markets

Fund Statistics

Assets Under Management$1.92 billion
Average Daily Volume$14,048.50

ETF Expenses

Management Fee0.35%
Other Expenses0.04%
Total Expenses0.39%
Fee Waiver-0.04%
Net Expenses0.35%

Administrator, Advisor and Custodian

AdministratorVan Eck Associates Corporation
AdvisorVan Eck Associates Corporation
CustodianThe Bank of New York Mellon Corporation
DistributorVan Eck Securities Corporation
Transfer AgentThe Bank of New York Mellon Corporation
Lead Market MakerVirtu Financial

Geographic Exposure of BBH

Currency Exposure of BBH

Sector Exposure of BBH

Industry Exposure of BBH

-1.55 (-0.88 %)
(As of 04/12/2021 03:06 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BBH News and Ratings via Email

Sign-up to receive the latest news and ratings for BBH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

VanEck Vectors Biotech ETF (NASDAQ:BBH) Frequently Asked Questions

What stocks does MarketBeat like better than VanEck Vectors Biotech ETF?

Wall Street analysts have given VanEck Vectors Biotech ETF a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but VanEck Vectors Biotech ETF wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting VanEck Vectors Biotech ETF?

VanEck Vectors Biotech ETF saw a drop in short interest in the month of March. As of March 15th, there was short interest totaling 12,200 shares, a drop of 15.3% from the February 28th total of 14,400 shares. Based on an average daily trading volume, of 13,500 shares, the days-to-cover ratio is presently 0.9 days.
View VanEck Vectors Biotech ETF's Short Interest

How has VanEck Vectors Biotech ETF's stock price been impacted by Coronavirus (COVID-19)?

VanEck Vectors Biotech ETF's stock was trading at $126.82 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, BBH shares have increased by 38.2% and is now trading at $175.31.
View which stocks have been most impacted by COVID-19

How often does VanEck Vectors Biotech ETF pay dividends? What is the dividend yield for VanEck Vectors Biotech ETF?

VanEck Vectors Biotech ETF announced an annual dividend on Friday, December 18th. Investors of record on Tuesday, December 22nd will be paid a dividend of $0.608 per share on Monday, December 28th. This represents a yield of 0.35%. The ex-dividend date of this dividend is Monday, December 21st. This is a positive change from VanEck Vectors Biotech ETF's previous annual dividend of $0.42.
View VanEck Vectors Biotech ETF's dividend history

Is VanEck Vectors Biotech ETF a good dividend stock?

VanEck Vectors Biotech ETF pays an annual dividend of $0.61 per share and currently has a dividend yield of 0.34%.
View VanEck Vectors Biotech ETF's dividend history.

Who are some of VanEck Vectors Biotech ETF's key competitors?

What other stocks do shareholders of VanEck Vectors Biotech ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Vectors Biotech ETF investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), (SNY), Intel (INTC), Micron Technology (MU), Cidara Therapeutics (CDTX), Quest Diagnostics (DGX), (MRNA) and Novavax (NVAX).

What is VanEck Vectors Biotech ETF's stock symbol?

VanEck Vectors Biotech ETF trades on the NASDAQ under the ticker symbol "BBH."

How do I buy shares of VanEck Vectors Biotech ETF?

Shares of BBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is VanEck Vectors Biotech ETF's stock price today?

One share of BBH stock can currently be purchased for approximately $175.31.

How much money does VanEck Vectors Biotech ETF make?

VanEck Vectors Biotech ETF has a market capitalization of $494.72 million.

This page was last updated on 4/12/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.